Effect of n-3 PUFA supplementation at different EPA:DHA ratios on the spontaneously hypertensive obese rat model of the metabolic syndrome
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The increasing incidence of the metabolic syndrome (MetS), a combination of risk factors before the onset of CVD and type 2 diabetes, encourages studies on the role of functional food components such as long-chain n-3 PUFA as preventive agents. In the present study, we explore the effect of EPA and DHA supplementation in different proportions on spontaneously hypertensive obese (SHROB) rats, a model for the MetS in a prediabetic state with mild oxidative stress. SHROB rats were randomised into four groups (n 7), each supplemented with EPA/DHA at ratios of 1:1, 2:1 and 1:2, or soyabean oil as the control for 13 weeks. The results showed that in all the proportions tested, EPA/DHA supplementation significantly lowered total and LDL-cholesterol concentrations, compared with those of the control group. EPA/DHA supplementation at the ratios of 1:1 and 2:1 significantly decreased inflammation (C-reactive protein levels) and lowered oxidative stress (decreased excretion of urinary isoprostanes), mainly at the ratio of 1:2. The activity of antioxidant enzymes increased in erythrocytes, abdominal fat and kidneys, with magnitudes depending on the EPA:DHA ratio. PUFA mixtures from fish affected different MetS markers of CVD risk factors in SHROB rats, depending on the ratios of EPA/DHA supplementation. The activation of endogenous defence systems may be related to the reduction of inflammation and oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304 · cited 7×
“The metabolic syndrome (MetS) is a combination of features such as insulin resistance hypercholesterolaemia, hypertriacyl-glycerolaemia, hypertension or obesity (1) that makes subjects with the MetS highly prone to developing type 2 diabetes mellitus and CVD.”
BackgroundInfluentialYan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784 · cited 1×
“Also, recent results have shown that n-3 PUFA inhibit NLRP3 inflammasome activation((31)).”
Result(n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
Mozaffarian, D., & Wu, J. H. Y. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149633 · Cited by 368
Wei, M. Y., & Jacobson, T. A. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0210-3 · Cited by 284 · cited 1×
“A meta-analysis of clinical studies has revealed that both PUFA were similarly effective in decreasing TAG concentrations (26) ; however, the results of the SHROB model appeared to differ from the outcome of human studies.”
ResultNonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat
Takaya, K., Ogawa, Y., Hiraoka, J., Hosoda, K., Yamori, Y., Nakao, K., & Koletsky, R. J. (1996) · Nature Genetics · doi:10.1038/ng1096-130 · Cited by 207
García-Hernández, V. M., Gallar, M., Sánchez-Soriano, J., Micol, V., Roche, E., & García-García, E. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.812619 · Cited by 39
Cited by
Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
Lalia, A., & Lanza, I. (2016) · Nutrients · doi:10.3390/nu8060329 · Cited by 141
“oxidative stress versus 1:1 and 2:1 [54].”
Chen, C., Yu, X., & Shao, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139565 · Cited by 133
“A more recent study by Molinar-Toribio et al reported that the relatively high ratio of EPA/DHA supplementation significantly decreased inflammation status and resultantly improved the insulin sensitivity in pre-diabetic rats [40], which is accordant with our speculations.”
ResultGlencross, B. D., Bachis, E., Betancor, M. B., Calder, P., Liland, N., Newton, R., & Ruyter, B. (2025) · Reviews in Fisheries Science & Aquaculture · doi:10.1080/23308249.2024.2388563 · Cited by 89
Metadata
- Authors
- Molinar-Toribio, E., Pérez-Jiménez, J., Ramos-Romero, S., Romeu, M., Giralt, M., Taltavull, N., Muñoz-Cortes, M., Jáuregui, O., Méndez, L., Medina, I., & Torres, J. L.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-02-27
- Volume
- 113
- Issue
- 6
- Pages
- 878-887
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2170928586
- Cited by
- 51
- References
- 8
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of n-3 PUFA supplementation at different EPA:DHA ratios on the spontaneously hypertensive obese rat model of the metabolic syndrome. https://app.cochat.ai/papers/10.1017/s0007114514004437
- The paper
- Molinar-Toribio, E., Pérez-Jiménez, J., Ramos-Romero, S., Romeu, M., Giralt, M., Taltavull, N., Muñoz-Cortes, M., Jáuregui, O., Méndez, L., Medina, I., & Torres, J. L. (2015). Effect of n-3 PUFA supplementation at different EPA:DHA ratios on the spontaneously hypertensive obese rat model of the metabolic syndrome. British Journal of Nutrition. https://doi.org/10.1017/s0007114514004437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.